AAAAAA
Results: 1-25/45
Authors:
Asselah, T
Condat, B
Cazals-Hatem, D
Hassani, Z
Bernuau, J
Groussard, O
Mussot, S
Leseche, G
Marcellin, P
Erlinger, S
Valla, D
Citation: T. Asselah et al., Ectopic hepatocellular carcinoma arising in the left chest wall: a long-term follow-up, EUR J GASTR, 13(7), 2001, pp. 873-875
Authors:
Asselah, T
Condat, B
Sibert, A
Rivet, P
Lebray, P
Bernuau, J
Benhamou, JP
Erlinger, S
Marcellin, P
Valla, D
Citation: T. Asselah et al., Haemobilia causing acute pancreatitis after percutaneous liver biopsy: diagnosis by magnetic resonance cholangiopancreatography, EUR J GASTR, 13(7), 2001, pp. 877-879
Authors:
Marcellin, P
de Bony, F
Garret, C
Altman, C
Boige, V
Castelnau, C
Laurent-Puig, P
Trinchet, JC
Rolan, P
Chen, C
Mamet, JP
Bidault, R
Citation: P. Marcellin et al., Influence of cirrhosis on lamotrigine pharmacokinetics, BR J CL PH, 51(5), 2001, pp. 410-414
Authors:
Di Martino, V
Rufat, P
Boyer, N
Renard, P
Degos, F
Martinot-Peignoux, M
Matheron, S
Le Moing, V
Vachon, F
Degott, C
Valla, D
Marcellin, P
Citation: V. Di Martino et al., The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: A long-term retrospective cohort study, HEPATOLOGY, 34(6), 2001, pp. 1193-1199
Authors:
Martinot-Peignoux, M
Boyer, N
Cazals-Hatem, D
Pham, BN
Gervais, A
Le Breton, V
Levy, S
Degott, C
Valla, DC
Marcellin, P
Citation: M. Martinot-peignoux et al., Prospective study on anti-hepatitis C virus-positive patients with persistently normal serum alanine transaminase with or without detectable serum hepatitis C virus RNA, HEPATOLOGY, 34(5), 2001, pp. 1000-1005
Authors:
Gervais, A
Martinot, M
Boyer, N
Auperin, A
Le Breton, W
Degott, C
Valla, D
Marcellin, P
Citation: A. Gervais et al., Quantitation of hepatic hepatitis C virus RNA in patients with chronic hepatitis C. Relationship with severity of disease, viral genotype and response to treatment, J HEPATOL, 35(3), 2001, pp. 399-405
Authors:
Zarski, JP
Barange, K
Souvignet, C
Bertini, M
Marcellin, P
Tran, A
Deugnier, Y
Couzigou, P
Plages, A
Ambroise-Thomas, P
Citation: Jp. Zarski et al., Efficacy and safety of lactosaminated human serum albumia-adenine arabinoside monophosphate in chronic hepatitis B patients non-responders to interferon therapy: a randomised clinical trial, J HEPATOL, 34(3), 2001, pp. 486-488
Authors:
Berson, A
Gervais, A
Cazals, D
Boyer, N
Durand, F
Bernuau, J
Marcellin, P
Degott, C
Valla, D
Pessayre, D
Citation: A. Berson et al., Hepatitis after intravenous buprenorphine misuse in heroin addicts, J HEPATOL, 34(2), 2001, pp. 346-350
Authors:
Gervais, A
Boyer, N
Marcellin, P
Citation: A. Gervais et al., Tolerability of treatments for viral hepatitis, DRUG SAFETY, 24(5), 2001, pp. 375-384
Authors:
Nejjari, M
Couvelard, A
Mosnier, JF
Moreau, A
Feldmann, G
Degott, C
Marcellin, P
Scoazec, JY
Citation: M. Nejjari et al., Integrin up-regulation in chronic liver disease: relationship with inflammation and fibrosis in chronic hepatitis C, J PATHOLOGY, 195(4), 2001, pp. 473-481
Authors:
Neuman, MG
Benhamou, JP
Malkiewicz, IM
Akremi, R
Shear, NH
Asselah, T
Ibrahim, A
Boyer, N
Martinot-Peignoux, M
Jacobson-Brown, P
Katz, GG
Le Breton, V
Le Guludec, G
Suneja, A
Marcellin, P
Citation: Mg. Neuman et al., Cytokines as predictors for sustained response and as markers for immunomodulation in patients with chronic hepatitis C, CLIN BIOCH, 34(3), 2001, pp. 173-182
Authors:
Durand, E
Danic, B
Tardivel, R
Semana, G
Gouezec, H
Martinot, M
Marcellin, P
Beauplet, A
Citation: E. Durand et al., Detection of an HCV chronic carrier state without anti-HCV antibody in a blood donor during 28 months, TRANSF CL B, 7(3), 2000, pp. 242-250
Authors:
Boyer, N
Marcellin, P
Citation: N. Boyer et P. Marcellin, Pegylated interferon: new progress in treatment for chronic hepatitis C, GASTRO CL B, 24(8-9), 2000, pp. 767-769
Authors:
Asselah, T
Martinot, M
Boyer, N
Marcellin, P
Citation: T. Asselah et al., Genetic variability of hepatitis c virus: clinical implications, GASTRO CL B, 24(2), 2000, pp. 175-184
Authors:
Marcellin, P
Benhamou, JP
Heathcote, J
Bismuth, H
Desmet, V
Guardia, J
Lok, A
Zum Buschenfeld, KHM
Pagliaro, L
Paumgartner, G
Rodes, J
Sherlock, S
Citation: P. Marcellin et al., A la carte interferon for hepatitis C?, HEPATOLOGY, 32(3), 2000, pp. 678-678
Authors:
de Man, RA
Marcellin, P
Habal, F
Desmond, P
Wright, T
Rose, T
Jurewicz, R
Young, C
Citation: Ra. De Man et al., A randomized, placebo-controlled study to evaluate the efficacy of 12-month famciclovir treatment in patients with chronic hepatitis B e antigen-positive hepatitis B, HEPATOLOGY, 32(2), 2000, pp. 413-417
Authors:
Di Martino, V
Thevenot, T
Boyer, N
Degos, F
Valla, D
Marcellin, P
Citation: V. Di Martino et al., Serum alanine transaminase level is a good predictor of response to interferon alfa therapy for chronic hepatitis B in human immunodeficiency virus-infected patients, HEPATOLOGY, 31(4), 2000, pp. 1030-1031
Authors:
Martinot-Peignoux, M
Boyer, N
Le Breton, V
Le Guludec, G
Castelnau, C
Akremi, R
Marcellin, P
Citation: M. Martinot-peignoux et al., A new step toward standardization of serum hepatitis C virus-RNA quantification in patients with chronic hepatitis C, HEPATOLOGY, 31(3), 2000, pp. 726-729
Authors:
Tuveri, R
Jaffredo, F
Lunel, F
Nalpas, B
Pol, S
Feray, C
Marcellin, P
Thibault, V
Delagneau, JF
Opolon, P
Scarpa, B
Brechot, C
Thiers, V
Citation: R. Tuveri et al., Impact of TT virus infection in acute and chronic, viral- and non viral-related liver diseases, J HEPATOL, 33(1), 2000, pp. 121-127
Authors:
Gervais, A
Bacq, Y
Bernuau, J
Martinot, M
Auperin, A
Boyer, N
Kilani, A
Erlinger, S
Valla, D
Marcellin, P
Citation: A. Gervais et al., Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C, J HEPATOL, 32(2), 2000, pp. 293-299
Authors:
Carreno, V
Zeuzem, S
Hopf, U
Marcellin, P
Cooksley, WGE
Fevery, J
Diago, M
Reddy, R
Peters, M
Rittweger, K
Rakhit, A
Pardo, M
Citation: V. Carreno et al., A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis B, J HEPATOL, 32(2), 2000, pp. 317-324
Authors:
Boyer, N
Marcellin, P
Citation: N. Boyer et P. Marcellin, Pathogenesis, diagnosis and management of hepatitis C, J HEPATOL, 32, 2000, pp. 98-112
Authors:
Lefrere, JJ
Lerable, J
Mariotti, M
Bogard, M
Thibault, V
Frangeul, L
Loiseau, P
Bouchardeau, F
Laperche, S
Pawlotsky, JM
Cantaloube, JF
Biagini, P
de Lamballerie, X
Izopet, J
Defer, C
Lepot, I
Poveda, JD
Dussaix, E
Gerolami, V
Halfon, P
Buffet-Janvresse, C
Ferec, C
Mercier, B
Marcellin, P
Martinot-Peignoux, M
Gassain, M
Merel, P
Lamoril, J
Coste, J
Roudet-Thoraval, F
Citation: Jj. Lefrere et al., Lessons from a multicentre study of the detectability of viral genomes based on a two-round quality control of GB virus C (GBV-C)/hepatitis G virus (HGV) polymerase chain reaction assay, J VIROL MET, 85(1-2), 2000, pp. 117-124
Authors:
Berger, L
Descamps, V
Marck, Y
Dehen, L
Grossin, M
Crickx, B
Marcellin, P
Belaich, S
Citation: L. Berger et al., Eczematous skin lesions induced by alpha interferon in atopic patients infected by hepatitis C virus: four cases., ANN DER VEN, 127(1), 2000, pp. 51-55
Authors:
Habersetzer, F
Boyer, N
Marcellin, P
Bailly, F
Ahmed, SNS
Alam, J
Benhamou, JP
Trepo, C
Citation: F. Habersetzer et al., A pilot study of recombinant interferon beta-1a for the treatment of chronic hepatitis C, LIVER, 20(6), 2000, pp. 437-441